Nemolizumab Q4W improves IGA success maintenance by 11.8% over withdrawal in atopic dermatitis
Trial shows nemolizumab maintains skin results for atopic dermatitis
This Phase 3 randomized controlled trial evaluated nemolizumab in 507 adolescents and adults with moderate-to-severe atopic dermatitis who w…
A new trial found that nemolizumab helps maintain clear skin and reduce itching for adults and teens with moderate to severe atopic dermatit…
Ultra-processed food consumption is associated with metabolic syndrome, cardiovascular risk, and allergic diseases in children
Ultra-processed foods linked to childhood weight and heart risks
This narrative review synthesizes evidence regarding the impact of ultra-processed food (UPF) on pediatric health. High UPF intake is linked…
High intake of ultra-processed foods is linked to weight gain, metabolic issues, and higher rates of asthma and skin conditions in children.
Upadacitinib Treatment for Concurrent Atopic Dermatitis Vitiligo and Alopecia Areata
One drug improved skin, hair, and pigment in one man
A 57-year-old man with severe, refractory skin conditions showed significant improvement in dermatitis, vitiligo, and hair loss on upadaciti…
A single patient with three skin conditions saw dramatic improvement after taking upadacitinib for one year.
1 514 781 patients shows methylisothiazolinone allergy prevalence is 5.48% in dermatitis cases
Large review shows contact allergy to isothiazolinones affects many dermatitis patients
This systematic review and meta-analysis examined contact allergy prevalence to isothiazolinones in 1 514 781 dermatitis patients from 2000 …
A massive review of over 1.5 million patients found that contact allergy to isothiazolinones is common in dermatitis cases, with methylisoth…
Narrative review discusses Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis risks from various medications
A review explains which drugs may cause severe skin reactions like Stevens-Johnson Syndrome
This narrative review examines Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis associated with antibiotics, antiepileptics, allopuri…
This review looks at medications linked to rare but dangerous skin conditions. It helps doctors and patients understand the risks.
Early preterm birth linked to lower atopic dermatitis risk in large meta-analysis
Preterm birth linked to lower allergy risk in children
A meta-analysis of observational studies involving over 5 million children found that early preterm birth was associated with a reduced risk…
Babies born early may have lower odds of developing eczema and hay fever, a large analysis finds.
Real-world meta-analysis of baricitinib for atopic dermatitis shows variable outcomes
Real-world data shows baricitinib helps European patients with severe eczema
This real-world meta-analysis of 264 European patients with moderate-severe atopic dermatitis found that baricitinib improved EASI scores at…
A new analysis of real-world patients found baricitinib reduced eczema severity and itch for many people with moderate-to-severe atopic derm…
Narrative review of extracellular vesicles for atopic dermatitis notes significant methodological gaps and safety data limitations
New EV sources and delivery methods may help treat atopic dermatitis
This narrative review examines extracellular vesicles derived from pathogens, host cells, plants, and other sources for treating atopic derm…
A review explores how extracellular vesicles from various sources might offer new ways to treat atopic dermatitis, though more research is n…
Secondary analysis of Phase 3 trials shows lebrikizumab improves absolute EASI response in moderate-to-severe atopic dermatitis
New analysis shows lebrikizumab helps clear skin faster than placebo for atopic dermatitis
This secondary analysis of two Phase 3 trials evaluated lebrikizumab 250 mg Q2W versus placebo in adults and adolescents with moderate-to-se…
A look at two major trials found lebrikizumab led to significantly better skin clearing than placebo in adults and adolescents with moderate…
Narrative review explores gut microbiota links to atopic dermatitis pathogenesis and potential therapeutic strategies
Gut bacteria changes may offer new hope for atopic dermatitis
This narrative review examines the relationship between gut microbiota alterations and atopic dermatitis. The authors discuss dysbiosis, los…
A review suggests that gut microbiome imbalances and specific bacterial changes could play a role in skin inflammation, pointing to new prev…
Review highlights emerging mechanisms for allergic contact dermatitis management
Critical gaps remain in understanding allergic contact dermatitis sensitization thresholds
This narrative review discusses allergic contact dermatitis and notes critical gaps persist regarding tissue-resident memory T cells and pre…
A review of allergic contact dermatitis highlights emerging mechanisms that may support the development of more precise and effective therap…
Systematic review links antibiotic use, smoking, and air pollution to atopic dermatitis risk
Air Pollution And Smoking Linked To Eczema Risk Across All Ages
This systematic review synthesizes evidence on environmental exposures and atopic dermatitis risk across children, adults, and mixed-age pop…
Air pollution, smoking, and antibiotics are the strongest environmental triggers for eczema across children and adults.
All dermatitis Articles
- Nemolizumab Q4W improves IGA success maintenance by 11.8% over withdrawal in atopic dermatitis
- Ultra-processed food consumption is associated with metabolic syndrome, cardiovascular risk, and allergic diseases in children
- Upadacitinib Treatment for Concurrent Atopic Dermatitis Vitiligo and Alopecia Areata
- 1 514 781 patients shows methylisothiazolinone allergy prevalence is 5.48% in dermatitis cases
- Narrative review discusses Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis risks from various medications
- Early preterm birth linked to lower atopic dermatitis risk in large meta-analysis
- Real-world meta-analysis of baricitinib for atopic dermatitis shows variable outcomes
- Narrative review of extracellular vesicles for atopic dermatitis notes significant methodological gaps and safety data limitations
- Secondary analysis of Phase 3 trials shows lebrikizumab improves absolute EASI response in moderate-to-severe atopic dermatitis
- Narrative review explores gut microbiota links to atopic dermatitis pathogenesis and potential therapeutic strategies
- Review highlights emerging mechanisms for allergic contact dermatitis management
- Systematic review links antibiotic use, smoking, and air pollution to atopic dermatitis risk
- Systematic review and meta-analysis shows high atopic dermatitis prevalence in Ethiopia across regions
- Systematic review and meta-analysis shows moderate correlation between S. aureus colonization and atopic dermatitis severity
- Network meta-analysis of pediatric atopic dermatitis treatments shows dupilumab and pimecrolimus efficacy
- Systematic review and meta-analysis links swimming pool attendance to increased asthma risk in children
- Tralokinumab maintains efficacy in adults with moderate-to-severe atopic dermatitis up to 152 weeks
- Network meta-analysis of pharmacological interventions for hand-foot syndrome in cancer patients undergoing chemotherapy
- Serum specific IgE testing reveals dust mite sensitization in 37.0% of patients with allergic diseases in Ningbo, China
- Guideline-based nursing strategy for toxic epidermal necrolysis in an elderly patient
- Narrative review discusses ginsenosides for skin conditions including psoriasis and dermatitis with noted evidence gaps
- Case report describes sintilimab-associated toxic epidermal necrolysis in gastric carcinoma patient
- Review of cohort data finds AD linked to psoriasis risk and biologics associated with lower risk
- Gut microbial IgA coating levels in infancy differ between urban and agrarian cohorts, linked to allergic outcomes
- CXCL13 quantification in PBMCs and plasma distinguishes Sézary syndrome from other cutaneous T-cell lymphomas and dermatoses
- Meta-analysis of mercury exposure in children associates with higher prevalence of asthma, atopic dermatitis, and other allergic outcomes
- AI pipeline shows substantial agreement with dermatologists for grading atopic dermatitis erythema severity
- Early proactive TCS for infant AD linked to lower food allergy rates at age 3
- Meta-analysis finds oral JAK inhibitors increase HDL and LDL cholesterol levels in patients from RCTs
- Parental autoimmune diseases associated with increased risk of asthma, eczema in offspring
- Genetic study links H. pylori susceptibility to HLA and innate immunity genes, suggests causal disease relationships
- Network meta-analysis ranks upadacitinib highest for efficacy in moderate-to-severe atopic dermatitis
- Systematic review links PPARγ to atopic dermatitis pathogenesis and identifies it as a potential therapeutic target
- Placebo effect observed in double-blinded food challenges for dogs with atopic dermatitis
- Topical PDE4 inhibitors show efficacy in pediatric atopic dermatitis meta-analysis
- Review suggests chemokine inhibition as prospective therapeutic target for atopic dermatitis